Previous 10 | Next 10 |
ClearPoint Neuro (NASDAQ:CLPT) on Wednesday said it expanded its worldwide license and research deal with Philips to include access to technology to enable surgical navigation using computed tomography (CT). ClearPoint Maestro Brain Model for the Operating Room aims to enable highly accurate ...
SOLANA BEACH, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced expansion of their worldwide license and research agreemen...
SOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2022 first ...
ClearPoint Neuro, Inc. (NASDAQ:CLPT) traded at a new 52-week high today of $31.99. This new high was reached on above average trading volume as 10.3 million shares traded hands, while the average 30-day volume is approximately 189,000 shares. MRI Interventions Inc is a medical device com...
Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) traded today at $31.99, eclipsing its 52-week high. This new high was reached on above average trading volume as 10.3 million shares traded hands, while the average 30-day volume is approximately 190,000 shares. MRI Interventions Inc is a me...
SOLANA BEACH, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the B. Riley Securitie...
The COVID is a headwind for the business as case volumes continue to be affected. There is an excellent cadence of products in development and over 40 therapies in the pipelines, but there are uncertainties as to how successfully they will turn out. There are other risks that inve...
Image source: The Motley Fool. ClearPoint Neuro, Inc. (NASDAQ: CLPT) Q4 2021 Earnings Call Mar 01, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ClearPoint Neuro, Inc. (CLPT) Q4 2021 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Joe Burnett – Chief Executive Officer Danilo D’Alessandro – Chief Financial Officer Conference Call Participants Frank Takkinen – Lake Street Capital Marc W...
ClearPoint Neuro press release (NASDAQ:CLPT): FY GAAP EPS of -$0.69 misses by $0.01. Revenue of $16.3M (+27.0% Y/Y) in-line. For further details see: ClearPoint Neuro GAAP EPS of -$0.69 misses by $0.01, revenue of $16.3M in-line
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its ...
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...